Sagimet Biosciences Inc. Series A Common Stock (SGMT)

Typically moves ±9.61% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED

Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a 14-report earnings history dating back to Aug 21, 2023. Its average absolute post-earnings move is ±9.61%, and 42.9% of those reactions were positive. Its largest post-earnings gain was +39.01% (Apr 27, 2026) and its largest decline was -14.38% (Nov 14, 2024). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How SGMT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±9.61%

Positive %

42.9%

Negative %

57.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☀ PRE	-0.68%	open_in_new
May 12, 2026	☀ PRE	-0.65%	open_in_new
Apr 27, 2026	☀ PRE	+39.01%	open_in_new
Mar 11, 2026	☀ PRE	+3.89%	open_in_new
Nov 13, 2025	☀ PRE	-11.95%	open_in_new
Aug 13, 2025	☀ PRE	+0.95%	open_in_new
May 08, 2025	☀ PRE	-4.78%	open_in_new
Mar 12, 2025	☀ PRE	+3.83%	open_in_new
Nov 14, 2024	☀ PRE	-14.38%	open_in_new
Aug 14, 2024	☀ PRE	-6.75%	open_in_new
May 15, 2024	☀ PRE	+6.3%	open_in_new
Mar 25, 2024	☀ PRE	+16.32%	open_in_new
Nov 13, 2023	☀ PRE	-12.16%	open_in_new
Aug 21, 2023	☽ POST	-12.9%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.61%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →

Funds holding

$108306342

Total value held

Buying

17 added · 1 reduced

Blackrock, Inc.

$50830842 +722.03%

Federated Hermes, Inc.

$16130307 NEW BUY

State Street Corp

$15422061 +1449.13%

Goldman Sachs Group Inc

$5867734 +348.48%

Ameriprise Financial Inc

$4492807 NEW BUY

SEC Filing Types

description SCHEDULE 13G

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260817	open_in_new SEC.gov
144	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
8-K	20260813	open_in_new SEC.gov
4	20260812	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
144	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
SCHEDULE 13G	20260730	open_in_new SEC.gov
4	20260722	open_in_new SEC.gov

Frequently asked about SGMT earnings

When does Sagimet Biosciences Inc. Series A Common Stock report earnings next? expand_more

Sagimet Biosciences Inc. Series A Common Stock (SGMT)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does SGMT stock move after earnings? expand_more

Over 14 reports, SGMT has moved an average of ±9.61% the session after earnings, closing higher 42.9% of the time.

What was SGMT's biggest post-earnings move? expand_more

SGMT's largest post-earnings gain on record was +39.01% on Apr 27, 2026, and its largest decline was -14.38% on Nov 14, 2024.

Where can I find Sagimet Biosciences Inc. Series A Common Stock's SEC filings? expand_more

All of Sagimet Biosciences Inc. Series A Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.